Quarterly report [Sections 13 or 15(d)]

Earning (Loss) Per Share (Details)

v3.25.1
Earning (Loss) Per Share (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Numerator:        
Net income (loss) for basic earnings per share $ 17,931,827 $ (17,678,787) $ (50,366,134) $ (11,144,012)
Adjustments to net income (loss) available to shareholders        
Change in fair value of SPA warrant liabilities (374,796) 0 0 0
New convertible debentures interest and change in fair value (24,199,071) 0    
Convertible secured debentures interest and amortization 1,151,356 0    
Adjusted net loss for diluted earnings per share $ (5,490,684) $ (17,678,787) $ (50,366,134) $ (11,144,012)
Denominator:        
Weighted average shares used to compute basic EPS (in shares) 2,676,003 1,143,198 1,910,761 1,123,695
Dilutive effect of:        
Restricted and performance stock units (in shares) 1,197
SPA Warrants (in shares) 106,530 0
Convertible debt (in shares) $ 12,505,433    
Weighted average shares used to compute diluted EPS (in shares) 15,289,163 1,143,198 1,910,761 1,123,695
Basic loss per share (in dollars per share) $ 6.70 $ (15.46) $ (26.36) $ (9.92)
Diluted loss per share (in dollars per share) $ (0.36) $ (15.46) $ (26.36) $ (9.92)
Anti-dilutive securities excluded from shares outstanding:        
Total anti-dilutive securities excluded from shares outstanding (in shares) 1,005,413 1,026,695 13,617,386 1,026,695
Stock options        
Anti-dilutive securities excluded from shares outstanding:        
Total anti-dilutive securities excluded from shares outstanding (in shares) 25,023 85,683 25,023 85,683
Restricted and performance stock units        
Anti-dilutive securities excluded from shares outstanding:        
Total anti-dilutive securities excluded from shares outstanding (in shares) 333,168 66,989 333,178 66,989
Warrants        
Anti-dilutive securities excluded from shares outstanding:        
Total anti-dilutive securities excluded from shares outstanding (in shares) 438,889 530,808 545,419 530,808
Earnout shares        
Anti-dilutive securities excluded from shares outstanding:        
Total anti-dilutive securities excluded from shares outstanding (in shares) 208,333 208,333 208,333 208,333
Convertible debt        
Anti-dilutive securities excluded from shares outstanding:        
Total anti-dilutive securities excluded from shares outstanding (in shares) 0 134,882 12,505,433 134,882